ASSERTIO THERAPEUTICS, INC. Operating Lease Cost
ASSERTIO THERAPEUTICS, INC. reported Operating Lease Cost of $1.31 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2020-03-10
- ASSERTIO THERAPEUTICS, INC. operating lease, cost for fiscal 2019 was $1.31M.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2019-12-31 | $1.31M 10-K · filed 2020-03-10 |